Visualization of complete regression of pulmonary arterial remodeling on optical coherence tomography in a patient with pulmonary arterial hypertension

Circulation Journal

Volumn 78, Issue 11, 2014, Pages 2771-2773

  Dai, Zhehao ^a   Sugimura, Koichiro ^a   Fukumoto, Yoshihiro ^a   Tatebe, Shunsuke ^a   Miura, Yutaka ^a   Nochioka, Kotaro ^a   Aoki, Tatsuo ^a   Miyamichi Yamamoto, Saori ^a   Yaoita, Nobuhiro ^a   Satoh, Kimio ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CYCLOPHOSPHAMIDE; PREDNISOLONE; SILDENAFIL;

ADULT; CASE REPORT; DRUG DOSE ESCALATION; DRUG PULSE THERAPY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM REMODELING; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PULMONARY HYPERTENSION; SJOEGREN SYNDROME; TRICUSPID VALVE REGURGITATION; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; VASCULAR REMODELING;

ADULT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR REMODELING;

EID: 84933573741     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0224     Document Type: Note

References (11)

1. Tatebe S, Fukumoto Y, Sugimura K, Nakano M, Miyamichi S, Satoh K, et al. Optical coherence tomography as a novel diagnostic tool for distal type chronic thromboembolic pulmonary hypertension. Circ J 2010; 74: 1742–1744.
2. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies. J Am Coll Cardiol 2012; 59: 1058–1072.
3. Hou J, Qi H, Zhang M, Meng L, Han Z, Yu B, et al. Pulmonary vascular changes in pulmonary hypertension: Optical coherence tomography findings. Circ Cardiovasc Imaging 2010; 3: 344–345.
4. Dai Z, Fukumoto Y, Tatebe S, Sugimura K, Miura Y, Nochioka K, et al. OCT imaging for the management of pulmonary hypertension. JACC Cardiovasc Imaging 2014; 7: 843–845.
5. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; 30: 2493–2537.
6. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S55–S66.
7. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43–S54.
8. Miyamichi-Yamamoto S, Fukumoto Y, Sugimura K, Ishii T, Satoh K, Miura Y, et al. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease. Circ J 2011; 75: 2668–2674.
9. Domingo E, Grignola JC, Aguilar R, Montero MA, Arredondo C, Vazquez M, et al. In vivo assessment of pulmonary arterial wall fibrosis by intravascular optical coherence tomography in pulmonary arterial hypertension: A new prognostic marker of adverse clinical follow-up. Open Respir Med J 2013; 7: 26–32.
10. Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–488.
11. Tatebe S, Fukumoto Y, Sugimura K, Miura Y, Nochioka K, Aoki T, et al. Optical coherence tomography is superior to intravascular ultrasound for diagnosis of distal-type chronic thromboembolic pulmonary hypertension. Circ J 2013; 77: 1081–1083.